- HHS lays groundwork for new FDA rule on releasing CRLsThe Trump administration is pushing the FDA to cement the details behind its proactive public release of rejection letters sent to pharma companies. The push comes as an HHS spokesperson confirmed…Endpoints · 20d ago↗ source
- AstraZeneca, GSK intensify China ties with Sino Biopharm dealsThe U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.BioPharma Dive · 20d ago↗ source
- Affordable Care Act insurers want more premium increases as enrollment sagsFor the second year in a row, many Affordable Care Act insurers are proposing double-digit premium increases, driven by rising medical costs as well as federal policy changes.STAT